Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Conditions

Pain 6Neoplasms 6Cancer Pain 3Marijuana Abuse 2Neuralgia 1Multiple Sclerosis 1Diabetes Mellitus 1Chronic Pain 1

Interventions

nabiximols 1Ketamine 1KRN 5500 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
INDUSTRY × Neuralgia × nabiximols × Clear all
NCT02073474 2022-12-20

An Observational Post-Marketing Safety Registry of Sativex®

Jazz Pharmaceuticals

Completed
978 enrolled

Marijuana Abuse, Diabetes Mellitus, Multiple Sclerosis, Neoplasms, Neuralgia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡